25 min listen
Where are we now with CBD and other questions facing dermatology? Perspectives from Adam Friedman, MD
Where are we now with CBD and other questions facing dermatology? Perspectives from Adam Friedman, MD
ratings:
Length:
23 minutes
Released:
Jul 8, 2021
Format:
Podcast episode
Description
In Episode 7 of Derms and Conditions, our host James Del Rosso, DO talks with Adam Friedman, MD, Professor and Chair of Dermatology at The George Washington University School of Medicine & Health Sciences on the use of topical CBD in dermatology and the use of oral spironolactone in breast cancer patients.
Dr. Del Rosso and Dr. Friedman discuss many diverse topics on CBD including FDA regulations, counseling patients, and clinical studies on topical CBD gel in the treatment of xerosis and atopic dermatitis. They further discuss evidence regarding the risk of oral spironolactone in breast cancer recurrence along with effective ways to manage and counsel patients who have a personal or family history of breast cancer.
Dr. Del Rosso and Dr. Friedman discuss many diverse topics on CBD including FDA regulations, counseling patients, and clinical studies on topical CBD gel in the treatment of xerosis and atopic dermatitis. They further discuss evidence regarding the risk of oral spironolactone in breast cancer recurrence along with effective ways to manage and counsel patients who have a personal or family history of breast cancer.
Released:
Jul 8, 2021
Format:
Podcast episode
Titles in the series (79)
Relationships in Dermatology: Elevating Your Career Through Mentorship, Diversity, and Leadership with Amy McMichael, MD by Derms and Conditions